Akifumi Morinaka
Directeur/Membre du Conseil chez Rege Nephro Co. Ltd.
Postes actifs de Akifumi Morinaka
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
JAFCO Group Co. Ltd. (Private Equity)
 JAFCO Group Co. Ltd. (Private Equity) Investment ManagersFinance JAFCO Group Co. Ltd. (JAFCO Group) is the private equity arm of the parent firm, JAFCO (TSE: 8595), founded in 1973. The firm is headquartered in Tokyo, Japan. | Private Equity Investor | 01/11/2019 | - |
| Corporate Officer/Principal | 01/11/2019 | - | |
Rege Nephro Co. Ltd.
 Rege Nephro Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Rege Nephro Co. Ltd. is a company based in Kyoto, Japan that specializes in the research, development, production, and sales of renal disease treatment drugs. The Japanese company has developed a unique and realistic approach to induce high-efficiency differentiation from stem cells, with the aim of saving patients suffering from renal failure. The company's research and development activities focus on developing various solutions for renal disease and improving the quality of life of patients suffering from renal disease. Rege Nephro Co. was founded in 2019 by Kenji Nagafune. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Akifumi Morinaka
Anciens postes connus de Akifumi Morinaka
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CHORDIA THERAPEUTICS INC. | Directeur/Membre du Conseil | - | - |
Statistiques
Internationale
| Japon | 4 |
Opérationnelle
| Director/Board Member | 2 |
| Private Equity Investor | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Finance | 2 |
| Commercial Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CHORDIA THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
JAFCO Group Co. Ltd. (Private Equity)
JAFCO Group Co. Ltd. (Private Equity) Investment ManagersFinance JAFCO Group Co. Ltd. (JAFCO Group) is the private equity arm of the parent firm, JAFCO (TSE: 8595), founded in 1973. The firm is headquartered in Tokyo, Japan. | Finance |
Rege Nephro Co. Ltd.
Rege Nephro Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Rege Nephro Co. Ltd. is a company based in Kyoto, Japan that specializes in the research, development, production, and sales of renal disease treatment drugs. The Japanese company has developed a unique and realistic approach to induce high-efficiency differentiation from stem cells, with the aim of saving patients suffering from renal failure. The company's research and development activities focus on developing various solutions for renal disease and improving the quality of life of patients suffering from renal disease. Rege Nephro Co. was founded in 2019 by Kenji Nagafune. | Commercial Services |
- Bourse
- Insiders
- Akifumi Morinaka
- Expérience
